TOTAL                7
new                  T3-                  1 
U.S.                 Z8                   1 
inversion            A6.1-                1 
rules                G2.1                 1 
threaten             E3-                  1 
Pfizer-Allergan      Z99                  1 
deal                 N5                   1 
